{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:03:34Z","timestamp":1791378214679,"version":"4.3.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T00:00:00Z","timestamp":1465776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1627-7","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T12:52:43Z","timestamp":1465822363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999\u20132008"],"prefix":"10.1186","volume":"16","author":[{"given":"Gaute Reier","family":"Jenssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Vold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Hovland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Jacob","family":"Bangstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Nyg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bjerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"1627_CR1","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1681\/ASN.V961126","volume":"9","author":"BS Kaplan","year":"1998","unstructured":"Kaplan BS, Meyers KE, Schulman SL. The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol. 1998;9:1126\u201333.","journal-title":"J Am Soc Nephrol."},{"key":"1627_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/archpedi.156.9.893","volume":"156","author":"DM Williams","year":"2002","unstructured":"Williams DM, Sreedhar SS, Mickell JJ, Chan JC. Acute kidney failure: a pediatric experience over 20\u00a0years. Arch Pediatr Adolesc Med. 2002;156:893\u2013900.","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"3","key":"1627_CR3","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.2903\/j.efsa.2011.2090","volume":"9","author":"European Food Safety Authority, European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Food Safety Authority, European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2009. EFSA Journal. 2011;9(3):2090. Available from: http:\/\/www.efsa.europa.eu\/en\/efsajournal\/pub\/2090 .","journal-title":"EFSA Journal"},{"key":"1627_CR4","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005;365:1073\u201386.","journal-title":"Lancet."},{"key":"1627_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/1471-2334-14-265","volume":"14","author":"GR Jenssen","year":"2014","unstructured":"Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999\u20132008--a retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis. 2014;14:265.","journal-title":"BMC Infect Dis."},{"key":"1627_CR6","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/apa.12742","volume":"103","author":"GR Jenssen","year":"2014","unstructured":"Jenssen GR, Hovland E, Bangstad HJ, Nygard K, Vold L, Bjerre A. The incidence and aetiology of acute kidney injury in children in Norway between 1999 and 2008. Acta Paediatr. 2014;103:1192\u20137.","journal-title":"Acta Paediatr."},{"key":"1627_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3201\/eid1104.040833","volume":"11","author":"RM Lynn","year":"2005","unstructured":"Lynn RM, O'Brien SJ, Taylor CM, Adak GK, Chart H, Cheasty T, et al. Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis. 2005;11:590\u20136.","journal-title":"Emerg Infect Dis."},{"key":"1627_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0b013e31816a062f","volume":"27","author":"E Espie","year":"2008","unstructured":"Espie E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, et al. Surveillance of hemolytic uremic syndrome in children less than 15\u00a0years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996\u20132006. Pediatr Infect Dis J. 2008;27:595\u2013601.","journal-title":"Pediatr Infect Dis J."},{"key":"1627_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00431-009-1079-9","volume":"169","author":"A Schifferli","year":"2010","unstructured":"Schifferli A, von Vigier RO, Fontana M, Sparta G, Schmid H, Bianchetti MG, et al. Hemolytic-uremic syndrome in Switzerland: a nationwide surveillance 1997\u20132003. Eur J Pediatr. 2010;169:591\u20138.","journal-title":"Eur J Pediatr."},{"key":"1627_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S0950268800068102","volume":"110","author":"M Bitzan","year":"1993","unstructured":"Bitzan M, Ludwig K, Klemt M, Konig H, Buren J, Muller-Wiefel DE. The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect. 1993;110:183\u201396.","journal-title":"Epidemiol Infect."},{"key":"1627_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","volume":"43","author":"AR Constantinescu","year":"2004","unstructured":"Constantinescu AR, Bitzan M, Weiss LS, Christen E, Kaplan BS, Cnaan A, et al. Non-enteropathic hemolytic uremic syndrome: causes and short-term course. Am J Kidney Dis. 2004;43:976\u201382.","journal-title":"Am J Kidney Dis."},{"key":"1627_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/sj.ki.5001581","volume":"70","author":"N Besbas","year":"2006","unstructured":"Besbas N, Karpman D, Landau D, Loirat C, Proesmans W, Remuzzi G, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006;70:423\u201331.","journal-title":"Kidney Int."},{"key":"1627_CR13","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1093\/ndt\/gfs279","volume":"27","author":"T Barbour","year":"2012","unstructured":"Barbour T, Johnson S, Cohney S, Hughes P. Thrombotic microangiopathy and associated renal disorders. Nephrol Dial Transplant. 2012;27:2673\u201385.","journal-title":"Nephrol Dial Transplant."},{"key":"1627_CR14","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1111\/ajt.12297","volume":"13","author":"M Alberti","year":"2013","unstructured":"Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, et al. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant. 2013;13:2201\u20136.","journal-title":"Am J Transplant."},{"key":"1627_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1067\/mpd.2002.125908","volume":"141","author":"EJ Klein","year":"2002","unstructured":"Klein EJ, Stapp JR, Clausen CR, Boster DR, Wells JG, Qin X, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr. 2002;141:172\u20137.","journal-title":"J Pediatr."},{"key":"1627_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrneph.2012.196","volume":"8","author":"H Trachtman","year":"2012","unstructured":"Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nat Rev Nephrol. 2012;8:658\u201369.","journal-title":"Nat Rev Nephrol."},{"key":"1627_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0022-3476(94)70002-8","volume":"125","author":"JR Brandt","year":"1994","unstructured":"Brandt JR, Fouser LS, Watkins SL, Zelikovic I, Tarr PI, Nazar-Stewart V, et al. Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers. J Pediatr. 1994;125:519\u201326.","journal-title":"J Pediatr."},{"key":"1627_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0929-693X(96)83223-4","volume":"3","author":"A Bernard","year":"1996","unstructured":"Bernard A, Tounian P, Leroy B, Bensman A, Girardet JP, Fontaine JL. Digestive manifestations in hemolytic uremic syndrome in children. Arch Pediatr. 1996;3:533\u201340.","journal-title":"Arch Pediatr"},{"key":"1627_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","volume":"60","author":"P Ruggenenti","year":"2001","unstructured":"Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60:831\u201346.","journal-title":"Kidney Int."},{"key":"1627_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","volume":"290","author":"AX Garg","year":"2003","unstructured":"Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, et al. Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA. 2003;290:1360\u201370.","journal-title":"JAMA."},{"key":"1627_CR21","unstructured":"European Centre for Disease Prevention and Control. Factsheet. http:\/\/ecdc.europa.eu\/en\/healthtopics\/escherichia_coli\/basic_facts\/pages\/basic_facts.aspx . Accessed 15 Oct 2015."},{"key":"1627_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1542\/peds.110.2.371","volume":"110","author":"J Brandt","year":"2002","unstructured":"Brandt J, Wong C, Mihm S, Roberts J, Smith J, Brewer E, et al. Invasive pneumococcal disease and hemolytic uremic syndrome. Pediatrics. 2002;110:371\u20136.","journal-title":"Pediatrics."},{"key":"1627_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.patbio.2015.03.001","volume":"63","author":"C Picard","year":"2015","unstructured":"Picard C, Burtey S, Bornet C, Curti C, Montana M, Vanelle P. Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathol Biol (Paris). 2015;63:136\u201343.","journal-title":"Pathol Biol (Paris)"},{"key":"1627_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-4450","volume":"137","author":"G Ardissino","year":"2016","unstructured":"Ardissino G, Tel F, Possenti I, Testa S, Consonni D, Paglialonga F, et al. Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics. 2016;137:1\u20139.","journal-title":"Pediatrics."},{"key":"1627_CR25","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368:2169\u201381.","journal-title":"N Engl J Med."},{"key":"1627_CR26","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMc1100859","volume":"364","author":"AL Lapeyraque","year":"2011","unstructured":"Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, Oualha M, et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med. 2011;364:2561\u20133.","journal-title":"N Engl J Med."},{"key":"1627_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1757-7241-19-44","volume":"19","author":"L Krogvold","year":"2011","unstructured":"Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, et al. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med. 2011;19:44.","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"1627_CR28","unstructured":"Norwegian Institute of Public Health. E.coli-enteritis (including EHEC-infection and HUS) [In Norwegian]. http:\/\/www.fhi.no\/artikler\/?id=82709 . Accessed 30 Mar 2016."},{"key":"1627_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00467-011-2081-9","volume":"27","author":"H Pottel","year":"2012","unstructured":"Pottel H, Hoste L, Martens F. A simple height-independent equation for estimating glomerular filtration rate in children. Pediatr Nephrol. 2012;27:973\u20139.","journal-title":"Pediatr Nephrol."},{"key":"1627_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000320385","volume":"33","author":"MV Micheletti","year":"2010","unstructured":"Micheletti MV, Lavoratti G, Materassi M, Pela I. Hemolytic uremic syndrome: epidemiological and clinical features of a pediatric population in Tuscany. Kidney Blood Press Res. 2010;33:399\u2013404.","journal-title":"Kidney Blood Press Res."},{"key":"1627_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00431-009-1039-4","volume":"169","author":"J Scheiring","year":"2010","unstructured":"Scheiring J, Rosales A, Zimmerhackl LB. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur J Pediatr. 2010;169:7\u201313.","journal-title":"Eur J Pediatr"},{"key":"1627_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1086\/341940","volume":"186","author":"A Gerber","year":"2002","unstructured":"Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997\u20132000, in Germany and Austria: a prospective study. J Infect Dis. 2002;186:493\u2013500.","journal-title":"J Infect Dis."},{"key":"1627_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00467-014-2950-0","volume":"30","author":"K Buder","year":"2015","unstructured":"Buder K, Latal B, Nef S, Neuhaus TJ, Laube GF, Sparta G. Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome. Pediatr Nephrol. 2015;30:503\u201313.","journal-title":"Pediatr Nephrol."},{"key":"1627_CR34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1055\/s-0034-1375295","volume":"40","author":"R Wurzner","year":"2014","unstructured":"Wurzner R, Riedl M, Rosales A, Orth-Holler D. Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome (eHUS). Semin Thromb Hemost. 2014;40:508\u201316.","journal-title":"Semin Thromb Hemost."},{"key":"1627_CR35","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/jac\/dkv162","volume":"70","author":"M Agger","year":"2015","unstructured":"Agger M, Scheutz F, Villumsen S, Molbak K, Petersen AM. Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal. J Antimicrob Chemother. 2015;70:2440\u20136.","journal-title":"J Antimicrob Chemother."},{"key":"1627_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/cid\/cis299","volume":"55","author":"CS Wong","year":"2012","unstructured":"Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis. 2012;55:33\u201341.","journal-title":"Clin Infect Dis."},{"key":"1627_CR37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/cid\/cis196","volume":"54","author":"A Rosales","year":"2012","unstructured":"Rosales A, Hofer J, Zimmerhackl LB, Jungraithmayr TC, Riedl M, Giner T, et al. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis. 2012;54:1413\u201321.","journal-title":"Clin Infect Dis."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1627-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-016-1627-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1627-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1627-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T16:56:27Z","timestamp":1656694587000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1627-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1627-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]},"article-number":"285"}}